Delivery Order SPE2DB20D3103-SPE2DB21FQ3K3
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,487.12 Firm Fixed Price delivery order contract is for the supply of Effexor XR 75 mg capsules to support military treatment facilities and healthcare programs. The contract has a performance period through March 7, 2024 and does not include any set-aside designations, indicating open competition. Amerisourcebergen holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,070.60 Firm Fixed Price delivery order is for the supply of EFFEXOR XR 37.5 MG CAPSULE UU 30S, a mental health medication. The contract has an ultimate completion date of August 26, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Effexor XR 37.5 mg capsules. The contract, valued at $37,348.50, is a firm fixed-price delivery order that does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which is a for-profit organization registered in the System for Award...
- This federal contract award, valued at $12,516.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EFFEXOR XR 37.5 MG CAPSULE 90S, a prescription medication. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,478.23 firm fixed-price delivery order is for the supply of EFFEXOR XR 37.5 MG CAPSULE 90S, a mental health treatment medication. The contract has an ultimate completion date of November 17, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $5,963.92, is for the delivery of Effexor XR 37.5 mg capsules to support federal healthcare programs. The contract is a Firm Fixed Price Delivery Order and has an ultimate completion date of September 28, 2023. Amerisourcebergen Drug Corp is a subsidiary of the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $12,734.38, is a delivery order for Effexor XR 75 mg capsules. It is a firm-fixed-price contract type with a completion date of February 28, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Effexor XR 37.5 mg capsules to the Defense Logistics Agency (DLA). The $3,847.15 delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,914.40, is for the delivery of EFFEXOR XR 75 MG CAPSULE 90S, a prescription medication. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,769.79, is a delivery order contract for the supply of EFFEXOR XR 37.5 MG CAPSULE medical products. The contract has a firm fixed price pricing type and an ultimate completion date of May 31, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB21FQ3K3Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,319.32 firm fixed price delivery order is for the supply of 4554823065 - EFFEXOR XR 37.5 MG CAPSULE 90S. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The contract award was not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp has demonstrated its capacity to meet the diverse pharmaceutical needs of multiple government agencies, including the Department of Justice Federal Bureau of Investigation, through its extensive supply chain and distribution capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.3k | 9/17/21 |